You are here

Life sciences leader Labcorp (US) expands in Flanders

Flanders’ life sciences & health ecosystem continues to convince international companies of its strengths. Labcorp, a global leader in diagnostics and drug development headquartered in the US, has announced a new investment project at its European Operations Center in Mechelen (Flanders). What’s in the works? Labcorp will be expanding its automated clinical trial kit production line at the site.

From Flanders to EMEA in no time

Once the expansion project is completed, Labcorp’s Flanders-based site will be capable of producing clinical trial test kits for over 70 countries in Europe, the Middle East and Africa (EMEA). That’s more than twice as many as today! For reference, the Mechelen site served 27 markets in 2021.

“The added capacity supports our customers’ needs for faster, more convenient clinical trial testing and delivery across the EMEA region,” comments Jonathan DiVincenzo, president of the Clinical Trial Testing Solutions group at Labcorp Drug Development. “As we build up our capabilities in Flanders, researchers will experience more flexibility in ordering and turnaround times.”

1.1 million and counting

The site of action is Labcorp Drug Development’s European Operations Center in Mechelen, which opened in March 2021. Since then, the multi-use facility has produced over 1.1 million trial kits, which are used across Europe to support clinical studies in oncology, diabetes, kidney disease, autoimmune conditions and more. This only adds to Flanders’ clinical trial and study credentials. Did you know, for instance, that the region has one of the world’s fastest clinical trial procedures and ranks in the European top 3 for clinical trials per capita

In addition to the production of clinical trial kits, the Flanders-based Labcorp site is also responsible for clinical study logistics and support as well as dry ice production and distribution

The European Operations Center in Flanders expands Labcorp Central Laboratory Services’ capacity and supports future growth, providing additional flexibility in the event of disruptions or unexpected surges in demand.

Dr. Paul Kirchgraber
CEO of Labcorp Drug Development

Rooting in Flanders

With this expansion project, Labcorp is fortifying its footprint in Flanders’ successful business and research ecosystem for life sciences & health. Want to unravel this ecosystem in a virtual yet interactive way? Head to the Flanders360 platform and discover 300+ successful companies, universities, R&D centers, incubators and other players active in Flanders’ life sciences & health industry. 

Alternatively, check out our industry overview to learn more about the available tax, legal and other incentives for establishing your life sciences & health hub in Flanders. 

More info

Reported by
press release Labcorp
8 August 2022

More news about Flanders?

  • Regular updates
  • No spam

Interested in doing business in Flanders?

Let us help you!

  • We can introduce you to other companies, banks and regulators
  • We organize site visits to real estate locations
  • We assist with all legal aspects of setting up a business
  • We're an official government agency
  • Our services are completely free
  • We are a team of international experts

Receive our handbook to growing your business in Flanders

  • It's completely free.
  • Get an overview of all incentives relevant to your company.
  • Tax system explained in-depth.
  • Learn how to set up your business quickly.
  • Discover the benefits of Flanders (in addition to the chocolate).

In addition to the ebook, I agree to receive one or two follow-up emails